Senate Bill 1664
116th Congress(2019-2020)
Prescription Drug Price Reporting Act
Introduced
Introduced in Senate on May 23, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1664
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Prescription Drug Price Reporting Act
This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.
HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
May 23, 2019
05/23/2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
05/23/2019
Introduced in Senate
Public Record
Record Updated
Nov 1, 2022 6:02:36 AM